2BB score and signals
Recursion Pharmaceuticals, Inc.’s current 2BB score is 35 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 50 | Normal |
| Quality | 100 | Very Strong |
| Risk | 0 | Very Low |
Company facts
| CEO | Najat Khan |
| Headquarters | Salt Lake City, Utah, United States |
| Founded | 2013 |
| Employees | 600 |
| 52-week range | $2.77 – $7.18 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-03 | — | -0.2346 | — | $15.77M |
| 2026-08-05 | — | -0.2387 | — | $12.19M |
| 2026-05-04 | — | -0.2798 | — | $17.81M |
| 2026-02-25 | — | -0.322 | — | $25.08M |
2BBBullish & Bearish